Georgia Governor Perdue to Introduce Session on Venture Capital Investing at BIO VentureForum East

  • Contact: Contact Stephanie Fischer 202-962-9200,
  • Recommend
  • Tweet
  • Print
  • Email

Georgia Governor Perdue to Introduce Session on Venture Capital Investing at BIO VentureForum East

WASHINGTON, D.C. (April 4, 2005) -- Georgia Governor Sonny Perdue will welcome conference participants to the Biotechnology Industry Organization's (BIO) VentureForum East Conference to be held in Atlanta, Georgia on May 9-11, 2005. 

The Governor will speak at 8:15am and a plenary session on Venture Capital Investing Trends will follow at 8:30 am on Tuesday, May 10th, in the Windsor Ballroom of the InterContinetal Hotel-Buckhead. 

Russell M. Medford, MD, PhD, will moderate the roundtable session.  Dr. Medford is the President and CEO of AtheroGenics, Inc., and serves as the Chairman of the Georgia BioMedical Partnership.  Leading venture capital investors will discuss the current biotechnology investment climate and identify the critical issues facing biotech CEOs searching for private financing.  Panelists include:


  • John J. Borer III, President and Senior Managing Director, Rodman & Renshaw;
  • Kelly Holman, Founder and Managing Director, Genesys Capital Partners Inc.;
  • Garheng Kong, MD, PhD, General Partner, Intersouth Partners;
  • Deepa Pakianathan, PhD, General Partner, Delphi Ventures;
  • Mark Strobeck, PhD, Principal, SR One.


BIO VentureForum East is the largest annual East Coast regional investor conference for venture stage biotechnology and healthcare firms.  It features plenary sessions and workshops on financing and partnering trends in the biotechnology industry, networking receptions, and presentations by up to 120 biotech companies selected by an advisory board of equity capital leaders. 

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in 31 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

For more information about BIO VentureForum East or to register on-line, please visit http://bvf-east.bio.org/  Registration is complimentary for credentialed members of the news media.  Advance registration is required for freelance journalists and web publications and is available online until May 2nd.  Reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. 

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.